
Financial Performance - In Q1 2025, the company's sales revenue was 2,207.3 million and a 28.4% increase from Q1 2024's 505.9 million, compared to 239.7 million[5]. - The gross margin for Q1 2025 was 22.5%, slightly down from 22.6% in Q4 2024, and significantly up from 13.7% in Q1 2024[5]. - Net profit for Q1 2025 was 270.9 million in Q4 2024, and a 409.2% increase from 0.02 for Q1 2025, compared to 309,571, up from 323,422 for Q1 2025, compared to 196.3 million, a decrease of 31.0% from 237.3 million in Q1 2024[5]. - Research and development expenses for Q1 2025 were 217,035 in Q4 2024[31]. Capacity and Production - Capacity utilization increased to 89.6% in Q1 2025, up by 4.1 percentage points from the previous quarter[7]. - Total wafer sales reached 2,292,153 units in Q1 2025, representing a 15.1% increase from 1,991,761 units in Q4 2024 and a 27.7% increase from 1,794,891 units in Q1 2024[19]. - The capacity utilization rate improved to 89.6% in Q1 2025 from 85.5% in Q4 2024[19]. Cash Flow and Assets - Cash and cash equivalents decreased to 6,364,189 thousand in Q4 2024[27]. - Net cash used in operating activities for Q1 2025 was 1,449,842 in Q4 2024[37]. - Total assets as of March 31, 2025, were 49,161,248 at the end of 2024[35]. Liabilities and Equity - Total liabilities decreased to 17,291,590 at the end of 2024[35]. - The company’s total equity increased to 31,869,658, reflecting a growth of 1.1%[35]. - The debt-to-equity ratio was 34.9% in Q1 2025, down from 36.4% in Q4 2024[27]. Future Outlook - The company expects Q2 2025 revenue to decline by 4% to 6%, with a gross margin guidance of 18% to 20%[8]. - The company aims to enhance its resilience and risk management capabilities while focusing on its core business in the second half of 2025[8]. Regional Performance - Revenue from the China region accounted for 84.3% in Q1 2025, a decrease from 89.1% in Q4 2024 and an increase from 81.6% in Q1 2024[17]. Other Income - Other income, net for Q1 2025 was 140.8 million in Q4 2024[16]. Capital Expenditures - Capital expenditures for Q1 2025 were 1,660.1 million in Q4 2024[20].